Honestly, I wouldn’t put too much focus on the paper. With the recent fiasco in regards to published data that was garbage, I believe Dr. BP’s paper will face the standard peer review process. This could take months. They may be asking for more data, which he could provide from the M2M or severe trial. That would further support the initial 11 patients worth of data.